1998
DOI: 10.1016/s1357-2725(98)00005-3
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
28
2

Year Published

2002
2002
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(31 citation statements)
references
References 13 publications
1
28
2
Order By: Relevance
“…We found that TGF-␤ induced procollagen mRNA expression, protein levels, and promoter activity from NBF and ABF but cannot be antagonized by Dex treatment. A GR response element is present in the TGF-␤ gene promoter and is thus susceptible to CS treatment (31,35). We found that the expression of TGF-␤ was reduced by CS in normal cells but not in cells from asthmatics.…”
Section: Discussionmentioning
confidence: 80%
“…We found that TGF-␤ induced procollagen mRNA expression, protein levels, and promoter activity from NBF and ABF but cannot be antagonized by Dex treatment. A GR response element is present in the TGF-␤ gene promoter and is thus susceptible to CS treatment (31,35). We found that the expression of TGF-␤ was reduced by CS in normal cells but not in cells from asthmatics.…”
Section: Discussionmentioning
confidence: 80%
“…It is known that plasma TGF-ß1 levels are affected by steroid use, and there are also studies implying that the plasma level of TGF-ß1 is affected by sulfasalazine and other anti-inflammatory drugs (22,23). For this reason, the patients included in our study were those who for various reasons including patient noncompliance, economic factors or social security problems had not received any kind of treatment at all.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, such medications inhibit TGF--β1 activation by weakening the protein binding activating the cytokine with its membrane receptor. 26 These observations indicate that by blocking TGF -β1 function while inhibiting the inflammatory cascade this drug class exerts the antifibrotic effect in patients with AIH.…”
Section: -19mentioning
confidence: 95%